Argus Research Maintains Silk Road Medical(SILK.US) With Buy Rating, Raises Target Price to $32
Argus Research analyst David Toung maintains $Silk Road Medical(SILK.US)$ with a buy rating, and adjusts the target price from $24 to $32.According to TipRanks data, the analyst has a success rate of
Lake Street Maintains Silk Road Medical(SILK.US) With Buy Rating, Maintains Target Price $28
Lake Street analyst Frank Takkinen maintains $Silk Road Medical(SILK.US)$ with a buy rating, and maintains the target price at $28.According to TipRanks data, the analyst has a success rate of 38.5% a
Analysts' Top Healthcare Picks: Silk Road Medical (SILK), Eli Lilly & Co (LLY)
Does Silk Road Medical (NASDAQ:SILK) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
Silk Road Medical | 10-Q: Quarterly report
Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call Transcript
Evaluating Silk Road Medical: Insights From 6 Financial Analysts
Ratings for Silk Road Medical (NASDAQ:SILK) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of their
Silk Road Medical Price Target Raised to $21.00/Share From $19.00 by JP Morgan
Silk Road Medical Price Target Raised to $21.00/Share From $19.00 by JP Morgan
Silk Road Medical Is Maintained at Neutral by Piper Sandler
Silk Road Medical Is Maintained at Neutral by Piper Sandler
Express News | Piper Sandler Maintains Neutral on Silk Road Medical, Raises Price Target to $20
Silk Road Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 2.88% Piper Sandler $18 → $20 Maintains Neutral 03/07/2024 23.46% Argus Research → $24 Upgrades
Oppenheimer Reaffirms Their Buy Rating on Silk Road Medical (SILK)
Silk Road Medical Inc (SILK) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
Express News | Silk Road Medical Inc : Piper Sandler Raises Target Price to $20 From $18
Silk Road Medical Inc (SILK) Q1 2024 Earnings: Revenue Surpasses Expectations, Losses Narrow
Express News | Silk Road Medical Sees FY24 Revenue $194M-$198M Vs $195.923M Est
Express News | Silk Road Medical Inc FY2024 Rev View $195.9 Mln -- Lseg Ibes Data
Express News | Silk Road Medical Inc: Sees Revenue for Full Year 2024 to Range From $194 Mln to $198 Mln
Express News | Silk Road Medical Q1 Gross Profit USD 36.501 Million
Express News | Silk Road Medical Q1 Revenue USD 48.484 Million Vs. Ibes Estimate USD 44.7 Million
No Data